These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 7010179

  • 21. Advances in the clinical development of antiepileptic drugs.
    Porter RJ, Hessie BJ, Cereghino JJ, Gladding GD, Kupferberg HJ, Scoville B, White BG.
    Fed Proc; 1985 Jul; 44(10):2645-9. PubMed ID: 3891417
    [Abstract] [Full Text] [Related]

  • 22. The NCI Developmental Therapeutics Program.
    Collins JM.
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):271-3. PubMed ID: 16728938
    [No Abstract] [Full Text] [Related]

  • 23. Investigational new drugs in cancer chemotherapy.
    Peterson BA, Briscoe K.
    Minn Med; 1979 Jul; 62(7):536-8. PubMed ID: 386073
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Problems in organizing the chemotherapy of malignant neoplasms].
    Demidov VP, Shchors TA.
    Vopr Onkol; 1977 Jul; 23(11):3-8. PubMed ID: 595512
    [No Abstract] [Full Text] [Related]

  • 28. [Past and current problems in tumor research].
    von Wasielewski E, Sedlacek HH.
    Dtsch Med Wochenschr; 1986 Apr 18; 111(16):630-7. PubMed ID: 3956405
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical trials referral resource. Current clinical trials of G3139.
    Tock B, Zwiebel JA, Schoenfeldt M.
    Oncology (Williston Park); 2003 Sep 18; 17(9):1244-6, 1251-3, 1258. PubMed ID: 14569852
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Modified protocol for the testing of new synthetics in the L1210 lymphoid leukemia murine model in the DR&D program, DCT, NCI.
    Geran RI, Greenberg NH, Macdonald MM, Abbott BJ.
    Natl Cancer Inst Monogr; 1977 Mar 18; (45):151-3. PubMed ID: 927490
    [No Abstract] [Full Text] [Related]

  • 37. Increasing access to investigational drugs.
    Christian M.
    Clin Adv Hematol Oncol; 2004 Feb 18; 2(2):90-1. PubMed ID: 16163167
    [No Abstract] [Full Text] [Related]

  • 38. Technology evaluation: CC49 humanized radioimmunoconjugates, National Cancer Institute.
    Sheikh N.
    Curr Opin Mol Ther; 2003 Aug 18; 5(4):428-32. PubMed ID: 14513687
    [Abstract] [Full Text] [Related]

  • 39. Approaches to the development and marketing approval of drugs that prevent cancer.
    Kelloff GJ, Johnson JR, Crowell JA, Boone CW, DeGeorge JJ, Steele VE, Mehta MU, Temeck JW, Schmidt WJ, Burke G.
    Cancer Epidemiol Biomarkers Prev; 1995 Aug 18; 4(1):1-10. PubMed ID: 7894318
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.